Literature DB >> 27240946

Self-disproportionation of enantiomers via achiral gravity-driven column chromatography: A case study of N-acyl-α-phenylethylamines.

Alicja Wzorek1, Azusa Sato2, Józef Drabowicz3, Vadim A Soloshonok4.   

Abstract

Herein we report a study of the self-disproportionation of enantiomers (SDE) via gravity-driven achiral column chromatography of a series of amides derived from 1-phenylethylamine. We demonstrated that structural and electronic factors of the substituents play an important role in the observed magnitude of the SDE. For the first time, the SDE phenomenon of amides with that of thioamides was compared. We demonstrate that, in sharp contrast to amides, the substitution of the sulphur atom for the oxygen in the acyl group, strongly reduced the observed magnitude of the SDE. These results clearly indicate the importance of the hydrogen bonding for the formation of homo/hetero-chiral association responsible for manifestation of the SDE phenomenon.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amide bond; Enantiopurification; Gravity-driven column chromatography; Homo/hetero-chiral intermolecular interaction; SDE (self-disproportionation of enantiomers); SDE-phoric groups

Mesh:

Substances:

Year:  2016        PMID: 27240946     DOI: 10.1016/j.chroma.2016.05.044

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  2 in total

Review 1.  The self-disproportionation of enantiomers (SDE): a menace or an opportunity?

Authors:  Jianlin Han; Osamu Kitagawa; Alicja Wzorek; Karel D Klika; Vadim A Soloshonok
Journal:  Chem Sci       Date:  2018-01-15       Impact factor: 9.825

Review 2.  Recommended Tests for the Self-Disproportionation of Enantiomers (SDE) to Ensure Accurate Reporting of the Stereochemical Outcome of Enantioselective Reactions.

Authors:  Jianlin Han; Alicja Wzorek; Karel D Klika; Vadim A Soloshonok
Journal:  Molecules       Date:  2021-05-07       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.